REYATAZ

Product NDC

70518-0725

11-digit product format

705180725

Labeler code

70518

Product ID

70518-0725_8c55df23-63e7-d540-e053-2a95a90a2971

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

ATAZANAVIR

Dosage form

CAPSULE, GELATIN COATED

Route

ORAL

Labeler

REMEDYREPACK INC.

Application

NDA021567

Marketing category

NDA

Marketing start

2017-09-05

Marketing end

0000-00-00

Substance

ATAZANAVIR SULFATE

Active strength

200 mg/1

Pharmacologic classes

HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record